DNA RNA and Cells

08 Oct 2009 RXi Pharmaceuticals Presented New Pre-Clinical Animal Data at its Annual Investor Day
07 Oct 2009 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection
07 Oct 2009 Living Cell Technologies Reports Successful First Implant Of DIABECELLĀ® In New Zealand
28 Sep 2009 Vical Licensee Sanofi-aventis Completes Enrollment in Phase 3 Angiogenesis Trial
23 Sep 2009 Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
23 Sep 2009 Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
22 Sep 2009 Advanced Cell Completing Pre-Clinical Activities in Preparation for IND Filing
21 Sep 2009 Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
18 Sep 2009 MOLOGEN reaches further objective in clinical study
15 Sep 2009 Alnylam and Medtronic Present New Late-Stage Pre-clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease
14 Sep 2009 ALTAIR THERAPEUTICS REPORTS SUCCESSFUL PHASE I STUDY OF INHALED AIR645
14 Sep 2009 Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
14 Sep 2009 ZaBeCor Pharmaceuticals Begins Phase II Clinical Trial in Asthma Patients Following Positive Phase I Results
10 Sep 2009 StemCells, Inc. To Initiate First Ever Neural Stem Cell Trial In Myelination Disorder
10 Sep 2009 MESOBLAST'S PROPRIETARY STEM CELLS SUCCESSFULLY REPAIR/REGENERATE DAMAGED INTERVERTEBRAL DISC CARTILAGE
10 Sep 2009 Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral
09 Sep 2009 REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RADAR (Phase 2b) STUDY OF REG1 ANTICOAGULATION SYSTEM
08 Sep 2009 LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
08 Sep 2009 Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
03 Sep 2009 NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with SpiegelmerĀ® NOX-A12
01 Sep 2009 Gene Signal and Collaborators Publish GS-101 Clinical Data Suggesting Safe and Effective Inhibition of Abnormal Ophthalmic Blood Vessel Growth
31 Aug 2009 Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
27 Aug 2009 Geron Comments on FDA Hold on Spinal Cord Injury Trial
27 Aug 2009 Lakewood-Amedex Inc. to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains
25 Aug 2009 AVI BioPharma Phase 1 Proof of Concept and Safety Data for AVI-4658 in Duchenne Muscular Dystrophy Featured in Lancet Neurology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top